LIPISUM F

Composition:

• Active Ingredients:

  • Atorvastatin: 10 mg 

  • Fenofibrate: 160 mg

Formulation:

• Form: Tablet

• Dosage Strengths:

  • Atorvastatin 10 mg + Fenofibrate 160 mg

• Route of Administration: Oral

Status:

• Prescription Status: Prescription-only medication (Rx)

• Regulatory Approval: Approved by drug regulatory authorities (such as the FDA or equivalent) for the management of dyslipidemia, especially when multiple lipid abnormalities are present.

Benefits:

• Comprehensive Lipid Management:

  • Atorvastatin: A statin that lowers LDL (low-density lipoprotein) cholesterol and triglycerides while increasing HDL (high-density lipoprotein) cholesterol.

  • Fenofibrate: A fibrate that primarily lowers triglycerides and can modestly increase HDL cholesterol. It helps to address dyslipidemia, especially when triglycerides are elevated.

• Synergistic Effect: The combination of Atorvastatin and Fenofibrate provides a broader approach to managing dyslipidemia by targeting different aspects of lipid metabolism. This dual action can be more effective in patients with mixed dyslipidemia (high LDL and high triglycerides).

• Cardiovascular Risk Reduction: Effective in reducing the risk of cardiovascular events such as heart attacks and strokes by improving overall lipid profiles and reducing triglyceride levels.

• Improved Lipid Profiles: Helps in achieving better control of lipid levels in patients who may not respond adequately to monotherapy with either statins or fibrates alone.